Jorgos A.
- Country
- The Netherlands
- Department
- Emergency Department
Research Overview
Data & Insights
Has run more than one trial at 0 of 8 partner sites.
Specializations
Cardiovascular Medicine
Focuses on acute coronary events, atrial fibrillation, and heart failure management.
- Management of ST-elevation myocardial infarction
- Prevention of recurrent major adverse cardiovascular events
- Therapeutic strategies for chronic coronary syndrome
- Risk reduction in atherosclerotic cardiovascular disease
- Antithrombotic optimization in atrial fibrillation
Engages in studies targeting inflammation pathways in cardiovascular risk.
Oncology – Solid Tumors
Investigates treatment approaches for gastrointestinal, thoracic, and gynecologic malignancies.
- Neoadjuvant therapy for locally advanced rectal cancer
- Targeted therapy in HER2-positive esophageal adenocarcinoma
- Immunotherapy combinations for non‑small cell lung cancer
- Adjuvant strategies in colon cancer
- Fertility‑preserving protocols in cervical cancer
Emphasizes molecular profiling to guide personalized cancer care.
Hematology – Leukemia and Lymphoma
Dedicated to acute myeloid leukemia and B‑cell lymphomas.
- Novel agents for relapsed AML
- Combination immunotherapy in DLBCL
- Minimal residual disease assessment in leukemia
- Targeted inhibition in chronic lymphocytic leukemia
- Biomarker‑driven trials in myelodysplastic syndrome
Supports integration of targeted and cellular therapies.
Pulmonary and Respiratory
Addresses chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, and sarcoidosis.
- Anti‑fibrotic strategies for IPF
- Inflammatory modulation in sarcoidosis
- Exacerbation prevention in COPD
- Biomarker development for lung disease progression
- Quality‑of‑life outcomes in chronic respiratory disorders
Focuses on therapies that reduce lung inflammation and fibrosis.
Metabolic and Endocrine
Explores obesity, type 2 diabetes, and related metabolic risk.
- Weight‑loss interventions for obesity
- Cardiovascular risk mitigation in type 2 diabetes
- Lipoprotein(a) lowering strategies
- Metabolic syndrome management
- Impact of anti‑inflammatory agents on metabolic health
Links metabolic control to cardiovascular outcome improvement.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.